NUVB Nuvation Bio Inc.: institutional ownership and insider trading
259 funds reported holding $1.52B of Nuvation Bio Inc. in their latest 13F filings; in Q2 2026 funds net bought $107M, with 39 new positions and 27 funds selling out; over the last 12 months insiders bought $118K and sold $9.68M on the open market; over its last four quarters it reported revenue of $170M and net income of −$150M.
NUVB revenue and earnings
- Quarter ended Jun 30, 2026: revenue $31.7M, net income −$62.8M, EPS -0.18
- Quarter ended Mar 31, 2026: revenue $83.2M, net income $5.40M, EPS 0.01
- Quarter ended Dec 31, 2025: revenue $41.9M, net income −$36.6M, EPS -0.11
- Quarter ended Sep 30, 2025: revenue $13.1M, net income −$55.8M, EPS -0.16
Famous investors holding NUVB
- Stanley Druckenmiller (Duquesne Family Office): $25.8M, 0.5% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $7.65M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $7.09M, 0.0% of the portfolio
- David Einhorn (Greenlight Capital): $199K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $12.0M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $6.48M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $2.12M, 0.0% of the portfolio
Largest institutional holders of NUVB
- FMR LLC — $297M
- BlackRock, Inc. (BLK) — $157M
- Decheng Capital LLC — $147M
- VANGUARD GROUP INC — $139M
- VANGUARD CAPITAL MANAGEMENT LLC — $67.7M
- Omega Fund Management, LLC — $45.9M
- Laurion Capital Management LP — $44.4M
- UBS Group AG (UBS) — $42.6M
- STATE STREET CORP (STT, STT-PG) — $41.9M
- GEODE CAPITAL MANAGEMENT, LLC — $35.5M
Recent NUVB insider trades
- Aug 19, 2026: Hattersley Gary sold 100,000 shares ($709K)
- Jun 23, 2026: Wentworth Kerry sold 63,000 shares ($379K)
- Jun 23, 2026: Markel Stacy sold 125,000 shares ($754K)
- Jun 23, 2026: Sauvage Philippe sold 47,668 shares ($286K)
5%+ owners
- FMR LLC: 15.0% (Schedule 13G/A, filed May 12, 2025)
- BlackRock, Inc.: 6.4% (Schedule 13G, filed Jul 17, 2025)
Who owns the most NUVB stock?
The largest institutional holders of Nuvation Bio Inc. in the latest 13F filings are FMR LLC ($297M), BlackRock, Inc. (BLK) ($157M), Decheng Capital LLC ($147M).
Are insiders buying or selling NUVB?
Over the last 12 months insiders bought $118K and sold $9.68M of Nuvation Bio Inc. stock on the open market (SEC Form 4).
Which famous investors own NUVB?
Stanley Druckenmiller, Renaissance Technologies, Two Sigma, David Einhorn, Ken Griffin.
What was NUVB's revenue last quarter?
Nuvation Bio Inc. reported revenue of $31.7M for the quarter ended June 30, 2026, with net income of −$62.8M.
Which ETFs hold NUVB?
15 ETFs and mutual funds hold it among their top 100 positions, including XPH, FYC, IWC, IHE.